Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
iCAN science seminar on Overcoming Undruggable Nature of Most Common Human Oncogene, K-Ras with Prof. Kevan Shokat
Welcome to the iCAN science seminar with Professor Kevan Shokat (UC San Francisco and UC Berkeley, Investigator, Howard Hughes Medical Institute) on…
iCAN science seminar on Decoding chaos – developing biomarkers in ovarian cancer with Prof. Iain McNeish
Welcome to the iCAN science seminar with Professor Iain McNeish (Imperial College London) on Decoding chaos – developing biomarkers in…
iCANDOC Motivated to complete Master’s on Time – with Award-Winning Results
The Faculty of Medicine, University of Helsinki awarded the best Master’s theses of 2024 at a ceremony on Friday, March…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
